Dr. Sung Ho Lee
Claim this profileNyack Hospital
Studies Breast Cancer
Studies Lung Cancer
11 reported clinical trials
23 drugs studied
Area of expertise
1Breast Cancer
HER2 positive
ER positive
Stage I
2Lung Cancer
Stage III
Stage II
Stage I
Affiliated Hospitals
Clinical Trials Sung Ho Lee is currently running
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Tazemetostat + Lenalidomide + Rituximab
for Follicular Lymphoma
The participants of this study would have relapsed/refractory follicular lymphoma. Follicular lymphoma is a type of blood cancer. It is referred to as 'relapsed' when the disease has come back after a period of improvement after that follows a treatment regimen and 'refractory' when treatment no longer works. Stage 1 of this trial will study the safety and the level that adverse effects of each of the study drug combinations can be tolerated (known as tolerability). It is also designed to establish a recommended study drug dosage for stage 2 and 3. Stage 1 of the study is completed. Stages 2 and 3 will evaluate and compare how long participants live without their disease getting worse when receiving the study drug in combination with other drug treatment versus the placebo (dummy drug) in combination with other drug treatment.
Recruiting1 award Phase 34 criteria
More about Sung Ho Lee
Clinical Trial Related6 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Sung Ho Lee has experience with
- Placebo
- Ianalumab
- Lenalidomide
- Tazemetostat
- Rituximab
- M7824
Breakdown of trials Sung Ho Lee has run
Breast Cancer
Lung Cancer
Thrombocytopenic Purpura
Breast cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sung Ho Lee specialize in?
Sung Ho Lee focuses on Breast Cancer and Lung Cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER positive.
Is Sung Ho Lee currently recruiting for clinical trials?
Yes, Sung Ho Lee is currently recruiting for 3 clinical trials in Nyack New York. If you're interested in participating, you should apply.
Are there any treatments that Sung Ho Lee has studied deeply?
Yes, Sung Ho Lee has studied treatments such as Placebo, Ianalumab, Lenalidomide.
What is the best way to schedule an appointment with Sung Ho Lee?
Apply for one of the trials that Sung Ho Lee is conducting.
What is the office address of Sung Ho Lee?
The office of Sung Ho Lee is located at: Nyack Hospital, Nyack, New York 10960 United States. This is the address for their practice at the Nyack Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.